Target intelligence / Profile preview

TENM4 antisense RNA 1 (TENM4-AS1)

Target: TENM4-AS1
Molecular classification: Other, Long non-coding RNA, Antisense RNA—predicted

Overview

TENM4 antisense RNA 1 (TENM4-AS1) is a predicted long non-coding natural antisense transcript overlapping the TENM4 gene. As of September 2025, there is no validated literature describing its sequence, alternative names, molecular function, role in disease, or use as a therapeutic target or biomarker. TENM4-AS1 may have been proposed based on genomic annotation or computational prediction, but further experimental characterization is absent. Most research focuses on the TENM4 protein, a transmembrane protein involved in neurodevelopment and cancer[1][2][4][5][6].

Beyond the preview

Go deeper on TENM4 antisense RNA 1 (TENM4-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TENM4 antisense RNA 1 (TENM4-AS1).

Explore the full profile